共 50 条
Survival in Pediatric Patients With Ventricular Assist Devices: A Special Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report
被引:5
|作者:
Ashfaq, Awais
[1
]
Lorts, Angela
[2
]
Rosenthal, David
[3
]
Adachi, Iki
[4
]
Rossano, Joseph
[5
]
Davies, Ryan
[6
]
Simpson, Kathleen E.
[7
]
Maeda, Katsuhide
[5
]
Wisotzkey, Bethany
[8
]
Koehl, Devin
[9
]
Cantor, Ryan S.
[9
]
Jacobs, Jeffrey P.
[1
,10
]
Peng, David
[1
,11
]
Kirklin, James K.
[9
]
Morales, David L. S.
[2
,12
]
机构:
[1] Johns Hopkins All Childrens Hosp, Heart Inst, St Petersburg, FL USA
[2] Cincinnati Childrens Hosp Med Ctr, Heart Inst, Cincinnati, OH USA
[3] Lucile Salter Packard Childrens Hosp, Dept Pediat Cardiol, Palo Alto, CA USA
[4] Texas Childrens Hosp, Dept Pediat Cardiac Surg, Houston, TX USA
[5] Childrens Hosp Philadelphia, Dept Pediat Cardiol & Cardiac Surg, Philadelphia, PA USA
[6] UT Southwestern, Dept Pediat Cardiac Surg, Dallas, TX USA
[7] Childrens Hosp Colorado, Dept Pediat Cardiol, Aurora, CO 80045 USA
[8] Phoenix Childrens Hosp, Dept Pediat Cardiol, Phoenix, AZ USA
[9] Univ Alabama Birmingham, Kirklin Inst Res Surg Outcomes, Birmingham, AL USA
[10] Univ Florida, Congenital Heart Ctr, Dept Surg, Div Cardiovasc Surg, Gainesville, FL USA
[11] CS Mott Childrens Hosp, Congenital Heart Ctr, Ann Arbor, MI USA
[12] UC Dept Pediat & Surg, Div Cardiothorac Surg, 3333 Burnett Ave, Cincinnati, OH 45229 USA
关键词:
OUTCOMES;
CHILDREN;
TEMPORARY;
D O I:
10.1016/j.athoracsur.2023.07.039
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BACKGROUND The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) provides detailed understanding on pediatric patients supported with ventricular assist devices (VADs). We sought to identify important variables affecting mortality in pediatric VADs.METHODS Patients aged <19 years, from 2012 to 2021, were included. Survival analyses were performed using KaplanMeier. Parametric hazard modeling was used to identify risk factors for death.RESULTS Of the 1109 patients, the most common devices were implantable continuous (IC, 448 [40%]), followed by paracorporeal pulsatile (PP, 306 [28%]), paracorporeal continuous (PC, 293 [26%]), and percutaneous (58 [5%]). Patients with percutaneous device, infants, congenital heart disease, biventricular support, and Interagency Registry for Mechanically Assisted Circulatory Support profile 1 had worse overall survival at 6 months. Positive outcome was 83% at 6 months. Consistent with their cohort composition, device type positive outcomes at 6 months were IC, 92%; PP, 84%; and PC, 69%. Parametric hazard modeling for overall survival showed an early hazard for death with biventricular support, congenital heart disease (CHD), intubation before implantation, PC device, and renal impairment, whereas a constant hazard was associated with ascites. For patients <10 kg, parametric modeling showed an early hazard for CHD, intubation, and renal impairment. Modeling in CHD patients showed an early hazard for biventricular support, renal impairment, and use of PC/PP devices.CONCLUSIONS This multivariable analysis of the complete Pedimacs database demonstrates that illness at VAD implantation, diagnosis, and strategy of support affect survival and differ by device type. We hope this is the first step in creating a predictive tool to help providers and families have informed expectations.(c) 2023 by The Society of Thoracic Surgeons. Published by Elsevier Inc.
引用
收藏
页码:972 / 979
页数:8
相关论文